Connection
Subbiah Pugazhenthi to Metabolic Syndrome
This is a "connection" page, showing publications Subbiah Pugazhenthi has written about Metabolic Syndrome.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
2.783 |
|
|
|
-
Tyagi A, Pugazhenthi S. A Promising Strategy to Treat Neurodegenerative Diseases by SIRT3 Activation. Int J Mol Sci. 2023 Jan 13; 24(2).
Score: 0.657
-
Tyagi A, Musa M, Labeikovsky W, Pugazhenthi S. Sirt3 deficiency induced down regulation of insulin degrading enzyme in comorbid Alzheimer's disease with metabolic syndrome. Sci Rep. 2022 11 17; 12(1):19808.
Score: 0.650
-
Tyagi A, Mirita C, Taher N, Shah I, Moeller E, Tyagi A, Chong T, Pugazhenthi S. Metabolic syndrome exacerbates amyloid pathology in a comorbid Alzheimer's mouse model. Biochim Biophys Acta Mol Basis Dis. 2020 10 01; 1866(10):165849.
Score: 0.548
-
Tyagi A, Nguyen CU, Chong T, Michel CR, Fritz KS, Reisdorph N, Knaub L, Reusch JEB, Pugazhenthi S. SIRT3 deficiency-induced mitochondrial dysfunction and inflammasome formation in the brain. Sci Rep. 2018 12 03; 8(1):17547.
Score: 0.494
-
Pugazhenthi S. Metabolic Syndrome and the Cellular Phase of Alzheimer's Disease. Prog Mol Biol Transl Sci. 2017; 146:243-258.
Score: 0.435